28.09
price down icon0.74%   -0.21
 
loading

Pfizer Inc 주식(PFE)의 최신 뉴스

pulisher
07:40 AM

24,909 Shares in Pfizer Inc. (NYSE:PFE) Purchased by Affinity Investment Advisors LLC - MarketBeat

07:40 AM
pulisher
Nov 01, 2024

PFIZER INC : UBS reiterates its Neutral rating - Marketscreener.com

Nov 01, 2024
pulisher
Nov 01, 2024

Leerink Partnrs Weighs in on Pfizer's Q4 Earnings (NYSE:PFE) - MarketBeat

Nov 01, 2024
pulisher
Nov 01, 2024

Pfizer Inc. (NYSE:PFE) Shares Bought by Lincluden Management Ltd. - MarketBeat

Nov 01, 2024
pulisher
Nov 01, 2024

Pfizer (NYSE:PFE) Upgraded at Evercore ISI - MarketBeat

Nov 01, 2024
pulisher
Nov 01, 2024

Pfizer Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next - Simply Wall St

Nov 01, 2024
pulisher
Oct 31, 2024

Pfizer faces lawsuit over withdrawn sickle cell drug - Daily Journal

Oct 31, 2024
pulisher
Oct 31, 2024

Pfizer Inc. (NYSE:PFE) Director Acquires $28,240.00 in Stock - MarketBeat

Oct 31, 2024
pulisher
Oct 31, 2024

Is Pfizer (NYSE:PFE) a High-Yielding Dividend Stock Worth Buying? - Yahoo Finance

Oct 31, 2024
pulisher
Oct 31, 2024

Pfizer director Scott Gottlieb purchases $28,240 in common stock - Investing.com

Oct 31, 2024
pulisher
Oct 31, 2024

Pfizer sees strong Q3, led by revenues for Covid vaccine, Paxlovid - Healthcare Brew

Oct 31, 2024
pulisher
Oct 31, 2024

Pfizer: Overstated Pessimism Makes Little Sense (NYSE:PFE) - Seeking Alpha

Oct 31, 2024
pulisher
Oct 31, 2024

Pfizer presents new AMPK activators - BioWorld Online

Oct 31, 2024
pulisher
Oct 31, 2024

Zacks Investment Ideas feature highlights: Pfizer, Philip Morris and Tenet Healthcare - Zacks Investment Research

Oct 31, 2024
pulisher
Oct 31, 2024

Is Pfizer Stock A Sell After Covid Products Drive Surprise Upside? - Investor's Business Daily

Oct 31, 2024
pulisher
Oct 31, 2024

Cantor Fitzgerald Boosts Earnings Estimates for Pfizer - MarketBeat

Oct 31, 2024
pulisher
Oct 31, 2024

Results: Pfizer Inc. Exceeded Expectations And The Consensus Has Updated Its Estimates - Yahoo Finance

Oct 31, 2024
pulisher
Oct 31, 2024

Pathway Financial Advisers LLC Sells 17,982 Shares of Pfizer Inc. (NYSE:PFE) - MarketBeat

Oct 31, 2024
pulisher
Oct 31, 2024

3 Factors That Make Pfizer's Ultra-High-Yield Dividend Safer Than You Might Think - The Motley Fool

Oct 31, 2024
pulisher
Oct 31, 2024

Diclofenac Patches Market Is Booming Worldwide 2024-2031 | - openPR

Oct 31, 2024
pulisher
Oct 30, 2024

Pfizer Inc. stock underperforms Wednesday when compared to competitors despite daily gains - MarketWatch

Oct 30, 2024
pulisher
Oct 30, 2024

Pfizer Covid sales boost prompts durability concernsBank of America - Proactive Investors USA

Oct 30, 2024
pulisher
Oct 30, 2024

Pfizer (NYSE:PFE) Stock Price Down 0.7%Here's What Happened - MarketBeat

Oct 30, 2024
pulisher
Oct 30, 2024

Pfizer boasts over 30% increase in Q3 revenues against previous year - Yahoo Finance

Oct 30, 2024
pulisher
Oct 30, 2024

Goldman Sachs raises Pfizer stock target, keeps buy rating on Paxlovid sales - Investing.com

Oct 30, 2024
pulisher
Oct 30, 2024

Pfizer Surpasses Q3 Expectations with Strong Earnings and Revenue Surge - Yahoo Finance

Oct 30, 2024
pulisher
Oct 30, 2024

Golden State Equity Partners Invests $1.04 Million in Pfizer Inc. (NYSE:PFE) - MarketBeat

Oct 30, 2024
pulisher
Oct 30, 2024

Here's Why Pfizer (PFE) is a Strong Value Stock - Yahoo Finance

Oct 30, 2024
pulisher
Oct 30, 2024

Pfizer Inc. Reports Strong Q3 2024 Results, Raises Guidance - MSN

Oct 30, 2024
pulisher
Oct 30, 2024

Are Wall Street Analysts Predicting Pfizer Stock Will Climb Or Sink? - Barchart

Oct 30, 2024
pulisher
Oct 30, 2024

Pfizer Third Quarter 2024 Earnings: Beats Expectations - Simply Wall St

Oct 30, 2024
pulisher
Oct 30, 2024

Pfizer (PFE) PT Raised to $33 at Goldman Sachs - StreetInsider.com

Oct 30, 2024
pulisher
Oct 30, 2024

PFIZER INC. (PFE) - MSN

Oct 30, 2024
pulisher
Oct 30, 2024

Pfizer reports Q3 2024 net income of $4.46bn - World Pharmaceutical Frontiers

Oct 30, 2024
pulisher
Oct 30, 2024

Pfizer Inc (PFE) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Raised Guidance - Yahoo Finance

Oct 30, 2024
pulisher
Oct 30, 2024

Pfizer rebuffs Starboard criticism as it raises forecasts - pharmaphorum

Oct 30, 2024
pulisher
Oct 29, 2024

Pfizer’s earnings crush estimates as company raises guidance - MSN

Oct 29, 2024
pulisher
Oct 29, 2024

Pfizer (PFE) Stock Movement Driven by Activist Investor Concerns - GuruFocus.com

Oct 29, 2024
pulisher
Oct 29, 2024

Why Pfizer Stock Tumbled on Tuesday - Yahoo Finance

Oct 29, 2024
pulisher
Oct 29, 2024

Pfizer CEO on company's 'exceptional quarter' & Starboard fight - Yahoo Finance

Oct 29, 2024
pulisher
Oct 29, 2024

Health Care Flat as Pfizer Weighs -- Health Care Roundup - Marketscreener.com

Oct 29, 2024
pulisher
Oct 29, 2024

Pfizer Inc. stock underperforms Tuesday when compared to competitors - MarketWatch

Oct 29, 2024
pulisher
Oct 29, 2024

Pfizer Braces for Activist Battle With Forecast Increase - MSN

Oct 29, 2024
pulisher
Oct 29, 2024

Pfizer Earnings: Maintaining Our Valuation as Management Pressed for Evidence of Productivity - Morningstar

Oct 29, 2024
pulisher
Oct 29, 2024

Pfizer raises full-year guidance by $1.5 billion amid activist investor pressure - Yahoo Finance

Oct 29, 2024
pulisher
Oct 29, 2024

Pfizer CEO defends performance after Starboard activist criticism - Financial Times

Oct 29, 2024
pulisher
Oct 29, 2024

Pfizer CEO Defends Record Against Activist Attack - Barron's

Oct 29, 2024
pulisher
Oct 29, 2024

Pfizer CEO: The activist investors are 'too late' - Yahoo Finance

Oct 29, 2024
pulisher
Oct 29, 2024

Pfizer sales of RSV vaccine ebb, but company gains market share - BioPharma Dive

Oct 29, 2024
pulisher
Oct 29, 2024

Pfizer’s Bourla Defends Strategy In The Wake Of Starboard’s Activist Investment - Scrip

Oct 29, 2024
pulisher
Oct 29, 2024

Pfizer’s Oncology Triumphs Keep Investors Hooked Amid Market Volatility - Seeking Alpha

Oct 29, 2024
pulisher
Oct 29, 2024

Pfizer (PFE) Raises Forecast, Braces for Fight With Starboard - Bloomberg

Oct 29, 2024
pulisher
Oct 29, 2024

Pfizer CEO, Under Fire, Will Do ‘Whatever It Takes’ to Grow (1) - Bloomberg Law

Oct 29, 2024
pulisher
Oct 29, 2024

Pfizer’s Strong Quarter Bolsters CEO’s Comeback Efforts - The Wall Street Journal

Oct 29, 2024
pulisher
Oct 29, 2024

Pfizer Results May Temper Efforts for Shakeup Demanded by Activist Investor - Investopedia

Oct 29, 2024
pulisher
Oct 29, 2024

Pfizer (NYSE:PFE) Shares Down 2.4%What's Next? - MarketBeat

Oct 29, 2024
pulisher
Oct 29, 2024

Key takeaways from Pfizer’s (PFE) Q3 2024 earnings report - AlphaStreet

Oct 29, 2024
pulisher
Oct 29, 2024

Pfizer Delivers Knockout Q3 Earnings Results, But Investors Are Unimpressed - Seeking Alpha

Oct 29, 2024
pulisher
Oct 29, 2024

Trending : Pfizer Raises Guidance After Strong 3Q - Marketscreener.com

Oct 29, 2024
pulisher
Oct 29, 2024

Trending: Pfizer Raises Guidance After Strong 3Q - Morningstar

Oct 29, 2024
pulisher
Oct 29, 2024

Why is Pfizer stock falling after Q3 results? (PFE:NYSE) - Seeking Alpha

Oct 29, 2024
pulisher
Oct 29, 2024

Pfizer rides Paxlovid sales growth to better than expected third quarter - CNA

Oct 29, 2024
pulisher
Oct 29, 2024

Pfizer’s guidance bump will not heal deeper wounds - Financial Times

Oct 29, 2024
pulisher
Oct 29, 2024

Pfizer CEO, Under Fire, Will Do ‘Whatever It Takes’ to Grow | Company Business News - Mint

Oct 29, 2024
pulisher
Oct 29, 2024

Ford Q3 earnings, Pfizer outlook amid Starboard fight: Morning Brief - Yahoo Finance

Oct 29, 2024
pulisher
Oct 29, 2024

Pfizer CEO defends turnaround strategy as activist pressures management - Reuters

Oct 29, 2024
pulisher
Oct 29, 2024

Nasdaq Surges Over 100 Points; Pfizer Earnings Top ViewsPfizer (NYSE:PFE) - Benzinga

Oct 29, 2024
$319.22
price down icon 0.29%
drug_manufacturers_general SNY
$53.27
price up icon 0.74%
$89.51
price up icon 0.78%
drug_manufacturers_general NVS
$109.35
price up icon 0.88%
drug_manufacturers_general MRK
$101.88
price down icon 0.43%
자본화:     |  볼륨(24시간):